Summer Haven Investment Management, LLC Vir Biotechnology, Inc. Transaction History

Summer Haven Investment Management, LLC

  • $158 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023
SELL
$23.2 - $27.29 $109,805 - $129,163
-4,733 Reduced 18.17%
21,312 $522,000
Q1 2023

Apr 13, 2023
BUY
$22.26 - $30.85 $15,626 - $21,656
702 Added 2.77%
26,045 $606,000
Q4 2022

Jan 18, 2023
BUY
$19.96 - $28.22 $8,303 - $11,739
416 Added 1.67%
25,343 $0
Q3 2022

Oct 20, 2022
BUY
$18.26 - $31.1 $455,167 - $775,229
24,927 New
24,927 $481,000

Others Institutions Holding VIR

# of Institutions
218
Shares Held
87M
Call Options Held
127K
Put Options Held
1.19M
View Full List

About Vir Biotechnology, Inc.

VIR Quotes by TradingView
  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $991M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Summer Haven Investment Management, LLC Portfolio

Follow Summer Haven Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summer Haven Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summer Haven Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email